Tag Bombay Stock Exchange

Mumbai: Sanofi Consumer Healthcare India Limited (“SCHIL”) (BSE: 544250, NSE: SANOFICONR) today announced its successful listing on BSE Limited (BSE) and the National Stock Exchange of India Limited (NSE). The milestone was marked with the ringing of the opening bell at BSE by Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited, signifying the listing of the company’s Equity Shares.

Ringing of the opening bell at BSE by Himanshu Bakshi, MD – Sanofi Consumer Healthcare India Limited, signifying the listing of the company’s Equity Shares.

Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited Commenting on this joyous occasion, he said, “India’s consumer healthcare market, has vast potential. SCHIL getting listed on BSE and NSE, marks a critical milestone for us; one that is further expected to strengthen our position and drive sustainable growth within the Indian market. By evaluating our business needs, capitalizing on emerging consumer trends in the healthcare space and encouraging a culture of digital innovations, we seek to address unmet consumer needs. For this, we aim to enhance our customer experience with our products.

Further, we remain committed to our mission, which is to make self-care as simple as it should be and empower our consumers to take control of their health. I am confident that our organisation’s consumer-first approach will drive our ambition to build the best ‘Fast Moving Consumer Healthcare’ (FMCH) organisation in and for the world.”

SCHIL has emerged as a distinct legal entity following its demerger from Sanofi India Limited. This demerger, executed under the Scheme of Arrangement, was sanctioned by the Mumbai bench of the National Company Law Tribunal and became effective on 1st June 2024. In alignment with Sanofi’s global strategy, SCHIL is now operating independently, with a dedicated focus on the Consumer Healthcare sector. SCHIL is committed to maintaining high standards of ethics, marketing practices, and business operations.

About Sanofi Consumer Healthcare India Limited (SCHIL): With an agile business model and strong brands, SCHIL is one of the leading players in India’s consumer healthcare market. Leveraging its global experience in consumer healthcare, Sanofi Consumer Healthcare India Limited (SCHIL) aims to enhance customer wellbeing through its portfolio of products which encompasses Allergy, Digestive Wellness, Pain Care, and Multivitamins and Herbal/Traditional Dietary Supplements. SCHIL’s key brands include Allegra®, DePURA®, Avil®, and Combiflam®. They are dedicated to building a healthier future for their customers by empowering people to take control of their health, through self-care and by addressing their everyday health concerns.

New Delhi, 15th July’24: Headquartered in Mumbai, India, Crest Ventures Limited a Non-Banking Finance Company registered with The Reserve Bank of India (RBI) and listed on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE) is excited to announce the launch of Crest Oaks, an iconic residential landmark situated in the heart of Marol, Andheri (E). Scheduled for completion before December 2027, this new development offers 130 Vastu-compliant residences available in 2, 3, and 3.5-bedroom layouts. Each Unit is thoughtfully designed to provide a harmonious blend of luxury and livability.

Unmatched Amenities and Excellent Connectivity

Crest Oaks features state-of-the-art amenities rarely found in the area spanning approximately 18,000 sq. ft. Residents can enjoy a fully-equipped fitness center, swimming pool, multipurpose court, jogging track, children’s play area, net cricket, a business center, and a party hall. The development also boasts a vehicle-free podium with a manicured garden, a landscaped terrace, a three-level non-stacked basement parking, and a four-tier security system. Strategically located, it offers convenient proximity to the airport, major commercial hubs, educational institutions, healthcare facilities, and entertainment centers, making it an ideal choice for discerning homebuyers.

A Vision of Luxury and Community

Nishka Choraria, Vice President of Marketing at Crest Ventures Limited, expressed her enthusiasm about the launch: “At Crest, we are dedicated to building exceptional living spaces that elevate the quality of life and create lasting value for our residents. We understand the effort and investment that goes into purchasing a home in Mumbai, and we take this responsibility very seriously. Our vision behind Crest Oaks is to craft a life of luxury for our residents as well as create a community where they can thrive and build lasting connections, fostering a sense of belonging and well-being.”

Legacy of Excellence

Crest Oaks is the third project Crest Ventures Limited has launched in Mumbai since 2021, marking the beginning of a robust pipeline of both residential and commercial projects planned across the city. Over the past two decades, Crest has earned a reputation for its dedication to crafting landmark residential and commercial spaces with thoughtful design, meticulous planning, and flawless execution. The Company has successfully delivered over 12 million sq. ft. of spaces across India, including landmark developments such as Phoenix Marketcity and Palladium Chennai, One Crest at Chennai, Crest Mukta in Mumbai, and Crest Greens in Raipur. Crest aims to continue building this legacy and establish itself as one of the most iconic developers in the city.